Simone P. Niclou

Formation of composite endothelial cell-mesenchymal stem cell islets : a novel approach to promote islet revascularization (2008)

Johansson, Ulrika, Rasmusson, Ida, Niclou, Simone P., Forslund, Naomi, Gustavsson, Linda, Nilsson, Bo, ...

 OBJECTIVE: Mesenchymal stem cells (MSCs) contribute to endothelial cell (EC) migration by producing proteases, thereby paving the way into the tissues for ECs. MSCs were added to our previously...

Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors (2004)

Ahmed, Bushra Y, Chakravarthy, Sridhara, Eggers, Ruben, Hermens, Wim TJMC, Zhang, Jing, Niclou, Simone P, ...

Abstract Background Inactivating genes in vivo is an important technique for establishing their function in the adult nervous system. Unfortunately, conventional knockout mice may suffer from several...

A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions

Niclou, Simone P., Danzeisen, Claude, Eikesdal, Hans P., Wiig, Helge, Brons, Nicolaas H. C., Poli, Aurélie M. F., ...

A NOD/Scid mouse expressing enhanced green fluorescent protein (eGFP) is described, in which human and mouse tumors marked with red fluorescent protein can be established in vivo, both at...

Formation of Composite Endothelial Cell–Mesenchymal Stem Cell Islets: A Novel Approach to Promote Islet Revascularization

Johansson, Ulrika, Rasmusson, Ida, Niclou, Simone P., Forslund, Naomi, Gustavsson, Linda, Nilsson, Bo, ...

OBJECTIVE—Mesenchymal stem cells (MSCs) contribute to endothelial cell (EC) migration by producing proteases, thereby paving the way into the tissues for ECs. MSCs were added to our previously...

iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype*

Rajcevic, Uros, Petersen, Kjell, Knol, Jaco C., Loos, Maarten, Bougnaud, Sébastien, Klychnikov, Oleg, ...

Malignant gliomas (glioblastoma multiforme) have a poor prognosis with an average patient survival under current treatment regimens ranging between 12 and 14 months. The tumors are characterized by...